News
Minnesota Cancer Clinical Trials Network Announces Development of Collaborative Statewide Educational Campaign
The Minnesota Cancer Clinical Trials Network (MNCCTN) is pleased to announce the development of a statewide educational campaign about clinical trials. The educational campaign aims to increase awareness and understanding of clinical…
Research from the University of Minnesota Influences FDA Decision to Move Towards Lowering Nicotine Levels in Cigarettes
A decades-long collaborative research effort that determined that a lower dose of nicotine in cigarettes led to a reduction in cigarette smoking, exposure to carcinogens and dependence, and an increase in attempts to quit has finally paid…
University of Minnesota Study Looks at Tobacco Use after Head and Neck Cancer Diagnosis
A new study out of the University of Minnesota looks at how posttreatment tobacco use in smokers with head and neck squamous cell carcinoma (HNSCC) changes over time. Tobacco use is well established as a carcinogen in HNSCC, meaning that…
Interim Title Dropped as Aaron Schilz, MPA, Named Masonic Cancer Center’s Executive Director
MINNEAPOLIS - May 23, 2022 - Aaron Schilz has been appointed as the Executive Director for the Masonic Cancer Center, University of Minnesota. He was previously named the Interim Executive Director in August of last year. He has been with…
U of M begins Phase I of first-in-human clinical trial for advanced solid tumor cancers
MINNEAPOLIS, MN - May 19, 2022 - Physicians and scientists at the University of Minnesota have opened a new solid tumor cancer clinical trial and have treated their first patient with HCW9218, an injectable, bifunctional immunotherapeutic…
Annual Cancer Research Symposium Returns to University of Minnesota
The Masonic Cancer Center’s Annual Research Symposium returns to the University of Minnesota after a two-year absence. Like many events that were affected during the global COVID-19 pandemic, this Annual Research Symposium showcasing the…
Kay Yow Cancer Fund Awards $100,000 Grant To Dr. Deepali Sachdev of Masonic Cancer Center
Minneaplis, MN (March 30, 2022) — The Kay Yow Cancer Fund® has awarded a $100,000 cancer research grant to Dr.
Dehm’s gene rearrangement research seeks to turn the tide on deadly prostate cancer
The renowned actor Sidney Poitier died of heart failure in January at age 94. He lived for nearly three decades following treatment for prostate cancer at age 66. Based on modeling estimates published a week after his death,…
U of M study asks whether evolutionary success might explain some cancers
A recent study out of the Masonic Cancer Center and University of Minnesota College of Veterinary Medicine looks at whether humans and dogs, both susceptible to cancer, are outliving the capacity of their natural cancer protective…
Dr. Emmanuel Antonarakis elected to The American Society for Clinical Investigation
The ASCI is pleased to announce the election of 95 new members for 2022.